Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent Immune Thrombocytopenia”

33 trials

Showing 20 of 33 results

Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT04056195
What this trial is testing

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Oscotec Inc. 61
Post-approval studies (Phase 4)Study completedNCT03119974
What this trial is testing

Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

Who this might be right for
Persistent or Chronic ITP
Assistance Publique - Hôpitaux de Paris 48
Large-scale testing (Phase 3)WithdrawnNCT02649504
What this trial is testing

Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University
Large-scale testing (Phase 3)Study completedNCT02868099
What this trial is testing

Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Kyowa Kirin China Pharmaceutical Co., Ltd. 203
Large-scale testing (Phase 3)Study completedNCT02076399
What this trial is testing

A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals 76
Not applicableNot Yet RecruitingNCT07268898
What this trial is testing

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 500
Post-approval studies (Phase 4)UnknownNCT05718856
What this trial is testing

TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083739
What this trial is testing

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 320
Not applicableStudy completedNCT03412188
What this trial is testing

The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Nayera Hazaa Elsherif 36
Testing effectiveness (Phase 2)UnknownNCT05232149
What this trial is testing

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Beijing InnoCare Pharma Tech Co., Ltd. 30
Not applicableLooking for participantsNCT06817395
What this trial is testing

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Massachusetts General Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT04200456
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 33
Testing effectiveness (Phase 2)Study completedNCT01880047
What this trial is testing

Safety and Efficacy of Eltrombopag at Escalated Doses

Who this might be right for
Immune ThrombocytopeniaPlatelet Disorder
Weill Medical College of Cornell University 35
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Not applicableStudy completedNCT03154385
What this trial is testing

Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 15
Not applicableLooking for participantsNCT07068126
What this trial is testing

Management of Children With Persistent ITP, A Novel Approach

Who this might be right for
Persistent Immune Thrombocytopenia
Assiut University 20
Large-scale testing (Phase 3)Study completedNCT02076412
What this trial is testing

A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals 74
Large-scale testing (Phase 3)Study completedNCT02077192
What this trial is testing

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals 123
Large-scale testing (Phase 3)Looking for participantsNCT05338190
What this trial is testing

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Assistance Publique - Hôpitaux de Paris 132
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation